A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

NCT05370144 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

RADIATION: Hypofractionated radiotherapy

Sponsor

AHS Cancer Control Alberta